Haleon (LON:HLN) Reaches New 1-Year Low - Here's Why

Key Points

• Shares of Haleon plc recently hit a new 52-week low of GBX 333.40 ($4.49), leading to discussions about whether it's a good time to sell.
• Wall Street analysts have mixed opinions on Haleon, with a consensus rating of "Hold" and an average price target of GBX 436.67.
• Insider Dawn Allen sold 64,329 shares at an average price of GBX 376, which raises questions about confidence in the company's stock.

Haleon plc (LON:HLN - Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 333.40 ($4.51) and last traded at GBX 333.68 ($4.51), with a volume of 2147000000 shares trading hands. The stock had previously closed at GBX 341 ($4.61).

Analysts Set New Price Targets

Several research firms have issued reports on HLN. Royal Bank Of Canada restated a "sector perform" rating and issued a GBX 370 price objective on shares of Haleon in a research note on Thursday, July 31st. JPMorgan Chase & Co. reiterated an "underweight" rating on shares of Haleon in a research report on Friday, August 1st. The Goldman Sachs Group restated a "buy" rating and set a GBX 440 target price on shares of Haleon in a research report on Wednesday, September 10th. Finally, Berenberg Bank cut their price objective on shares of Haleon from GBX 503 to GBX 500 and set a "buy" rating on the stock in a report on Friday, August 8th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of GBX 436.67.

Haleon Trading Down 2.5%

The company has a debt-to-equity ratio of 53.36, a quick ratio of 0.93 and a current ratio of 0.84. The firm's fifty day simple moving average is GBX 358.82 and its 200-day simple moving average is GBX 378.31. The stock has a market cap of £29.77 billion, a P/E ratio of 1,991.62, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19.

Haleon (LON:HLN - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported GBX 8.90 earnings per share for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. Equities research analysts expect that Haleon plc will post 19.5033282 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Dawn Allen sold 64,329 shares of Haleon stock in a transaction on Monday, June 30th. The stock was sold at an average price of GBX 376, for a total value of £241,877.04. Corporate insiders own 0.01% of the company's stock.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.